ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1431 • 2018 ACR/ARHP Annual Meeting

    Kikuchi-Fujimoto Disease: A Retrospective Analysis of 23 Pediatric Cases from a US Center

    Ekemini Ogbu1,2, Shanmuganathan Chandrakasan1,2, Sunita Park1,2 and Sampath Prahalad1,2, 1Pediatrics, Emory University, Atlanta, GA, 2Children's Healthcare of Atlanta, Atlanta, GA

    Background/Purpose: Kikuchi-Fujimoto Disease (KFD) is often described as a benign self-limited disease. However, there is a risk of recurrence. It is most common in adult…
  • Abstract Number: 1432 • 2018 ACR/ARHP Annual Meeting

    Engaging Patients and Parents to Improve Mental Health for Youth with Rheumatologic Disease

    Oluwatunmise Fawole1, Michelle Vickery2, Lauren Faust3, Tamar Rubinstein4, Julia Harris5, Aimee O. Hersh6, Karen Onel7, Erica Lawson8, Emily von Scheven9, Kaveh Ardalan10, Esi Morgan11, Anne Paul12, Judith Barlin13, R. Paola Daly13, Mitali Dave14, Shannon Malloy15, Shari Hume15, Suzanne Schrandt16, Laura C. Marrow17, Angela Chapson3, Donna Napoli3, Michael Napoli3, Miranda Moyer3, Rachel Adamski3, Vincent Del Gaizo18, Martha Rodriguez19 and Andrea M. Knight20, 1The Children's Hospital of Philadelphia, Philadelphia, PA, 2Hershey Medical Center, Hershey, PA, 3Children's Hospital of Philadelphia, Philadelphia, PA, 4Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, 5Children's Mercy - Kansas City, Kansas City, MO, 6Pediatrics/Rheumatology, University of Utah, Salt Lake City, UT, 7Division of Pediatric Rheumatology, University of Chicago, Chicago, IL, 8Pediatrics/Rheumatology, University of California, San Francisco, San Francisco, CA, 9Pediatric Rheumatology, University of California San Francisco, San Francisco, CA, 10Division of Rheumatology; Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine, Chicago, IL, 11University of Cincinnati, Cincinnati, OH, 12Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 13Lupus Foundation of America, Washington, DC, 14Cure JM Foundation, Encintas, CA, 15Cure JM Foundation, Encinitas, CA, 16Arthritis Foundation, Saint Paul, MN, 17Arthritis Foundation, Atlanta, GA, 18Parent Partner, Whitehouse Station, NJ, 19Riley Children’s Hospital at Indiana, Indianapolis, IN, 20Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Mental health conditions are common in youth with rheumatologic disease, yet intervention strategies are understudied. We used a patient-engaged approach to investigate the mental…
  • Abstract Number: 1433 • 2018 ACR/ARHP Annual Meeting

    The Role of Patient and Parental Resilience in Amplified Musculoskeletal Pain Syndrome

    Sabrina Gmuca1, Audrey Urquhart1, Pamela F. Weiss2, Jeffrey S. Gerber3 and David D. Sherry1, 1Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Division of Rheumatology, Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Resilience is a dynamic process of positive adaptation in the context of significant adversity. While higher levels of resilience have been associated with improved…
  • Abstract Number: 1434 • 2018 ACR/ARHP Annual Meeting

    Patient-Proxy Agreement on Health-Related Quality of Life in Juvenile Fibromyalgia Syndrome

    Sabrina Gmuca, Audrey Urquhart and David D. Sherry, Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: The administration of proxy-reported health-related quality of life (HRQoL) measures in the assessment of juvenile fibromyalgia syndrome (JFMS) is common but its added clinical…
  • Abstract Number: 1435 • 2018 ACR/ARHP Annual Meeting

    Hormonal Contraception Use and Capacity to Self-Screen for Contraindications Among Adolescents in a Pediatric Rheumatology Clinic

    Stacey Tarvin1, Tracey Wilkinson2, Tom Vielott2, Ashley Meredith3, Carolyn Meagher2 and Mary Ott4, 1Pediatric Rheumatology, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, 2Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, 3Purdue University, West Lafayette, IN, 4Adolescent Medicine, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN

    Background/Purpose: Many states allow pharmacists to prescribe combined hormonal contraception (HC), eliminating the barrier of a provider visit. For adolescent rheumatology patients, however, a clinician…
  • Abstract Number: 1436 • 2018 ACR/ARHP Annual Meeting

    Pregnancy Outcomes in Partners of DMARD Exposed Men with Juvenile Idiopathic Arthritis – an Observational Study

    Paula Drechsel1, Jens Klotsche2, Martina Niewerth2, Gerd Horneff3 and Kirsten Minden4, 1Epidemiology, German Rheumatism Research Center, Berlin, Germany, 2Program Area Epidemiology, German Rheumatism Research Center, Berlin, Germany, 3Asklepios Clinic Sankt Augustin, and University Hospital of Cologne, Cologne, Germany, 4Epidemiology unit, German Rheumatism Research Center and Charité University Medicine Berlin, Berlin, Germany

    Background/Purpose: Males account for about one third of all cases of juvenile idiopathic arthritis (JIA). During the course of the disease and often into adulthood,…
  • Abstract Number: 1437 • 2018 ACR/ARHP Annual Meeting

    Use,Safety and Efficacy of Thalidomide from a Tertiary Level Pediatric Rheumatology Centre in India

    Manjari Agarwal1 and Sujata Sawhney2, 1Institute of Child Health, Attending Consultant, New Delhi, India, 2Paediatric rheumatology, Senior Consultant, New Delhi, India

    Background/Purpose: Thalidomide is an effective agent for several pediatric rheumatic diseases: SOJIA, Behcet's disease and recalcitrant skin disease in cSLE to name a few. Systemic…
  • Abstract Number: 1438 • 2018 ACR/ARHP Annual Meeting

    Treatment and Response of Down Syndrome Arthropathy

    Jordan T. Jones1, Nasreen Talib2, Daniel J Lovell3 and Mara L Becker4, 1Rheumatology Division, Children's Mercy Kansas City, Kansas City, MO, 2General Pediatrics, Children's Mercy Kansas City, Kansas City, MO, 3Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 4Rheumatology, Children's Mercy Kansas City, Kansas City, MO

    Background/Purpose: Of the very few studies describing Down syndrome arthropathy (DA), crude prevalence estimates indicate DA maybe as common as juvenile idiopathic arthritis (JIA), however,…
  • Abstract Number: 1439 • 2018 ACR/ARHP Annual Meeting

    Yellow Fever Vaccination in Brazil: Short-Term Safety in Pediatric Autoimmune Rheumatic Diseases

    Nadia E Aikawa1, Verena A Balbi2, Adriana C Tonacio3, Adriana M E Sallum2, Lucia M A Campos2, Katia T. Kozu2, Margarete B Vendramini1, Nicole Fontoura1, Ana MC Sartori4, Leila Antonangelo5, Clovis A Silva2 and Eloisa Bonfa6, 1Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, 2Pediatric Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, 3Infectology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Infectology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, 5Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, 6Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Yellow fever (YF) immunization is not routinely performed in juvenile autoimmune rheumatic disease (ARD) patients. However, during the recent epidemic campaign in state of…
  • Abstract Number: 1440 • 2018 ACR/ARHP Annual Meeting

    Systemic Sclerosis in Pediatric Patients: An Epidemiological Study in a Large Insured Population in the US

    Alexander Michel1, Marcela Rivera2, Tatsiana Vaitsiakhovich2, Simon Teal2 and Janethe Pena3, 1Epidemiology, Bayer Basel, Basel, Switzerland, 2Real World Evidence, Bayer AG, Berlin, Germany, 3Clinical Development, Bayer US LLC, Whippany, NJ

    Background/Purpose: Systemic sclerosis (SSc) is a very rare autoimmune disorder and only very few population-based epidemiological studies described its incidence and prevalence in children. In…
  • Abstract Number: 1441 • 2018 ACR/ARHP Annual Meeting

    Diagnostic Performances of Antibodies Against Carbamylated Proteins in US Based Populations with Rheumatoid Arthritis and Other Autoimmune Rheumatic Diseases

    Jing Shi1, Jay Milo2, Kelley Bradey1, Chelsea Bentow2, John Conklin1, Tyler O'Malley1, Armida Sace1, Rowena Lafon1, Duncan Poling1, Claudia Ibarra1, Michael Mahler2 and Thierry Dervieux1, 1Exagen Diagnostics, Inc., Vista, CA, 2Research and Development, Inova Diagnostics, San Diego, CA

    Background/Purpose: Recently, antibodies directed against carbamylated antigens (anti-CarP antibodies) were identified in rheumatoid arthritis (RA). Studies have established the predictive and prognostic value of this…
  • Abstract Number: 1442 • 2018 ACR/ARHP Annual Meeting

    Differential Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry and a Universal Metabolome Standard Reveals a Metabolome Profile with Consistent Accuracy for Rheumatoid Arthritis

    Walter P. Maksymowych1, Xiaohang Wang2, Joel Paschke1, Rana Dadashova1, Edna Hutchings1 and Liang Li2, 1CaRE Arthritis, Edmonton, AB, Canada, 2Chemistry, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Early diagnosis of rheumatoid arthritis (RA) is hampered by suboptimal accuracy of currently available serological biomarkers. Recent advancements in metabolomic profiling include dansylation liquid…
  • Abstract Number: 1443 • 2018 ACR/ARHP Annual Meeting

    Ultrasonographic Criteria for the Diagnosis of Erosive Rheumatoid Arthritis Disease Using Osteoarthritic Patients As Controls Compared to Validated Radiographic Criteria

    Camille Roux1, Frédérique Gandjbakhch2, Audrey Pierreisnard3, Marion Couderc4, Cédric Lukas5, Racha Masri1, Jean-Philippe Sommier1, Isabelle Clerc-Urmès6, Cedric Baumann7, Isabelle Chary-Valckenaere8 and Damien Loeuille9, 1Rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 2UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France, 3APHP, Paris, France, 4Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 5Rheumatology, Lapeyronie Hospital and EA2415 Montpellier University, Montpellier, France, 6CHRU Nancy, Nancy, France, 7CHRU Nancy, Vandoeuvre les Nancy, France, 8Rheumatology, CHRU Nancy, Vandoeuvres les Nancy, France, 9Rheumatology, University Hospital of Nancy, NANCY, France

    Background/Purpose: Rheumatoid arthritis (RA) is the most prevalent chronic inflammatory joint disease (1,2) responsible for structural damage. Radiography (RX) is considered as the gold standard…
  • Abstract Number: 1444 • 2018 ACR/ARHP Annual Meeting

    Optimization of Ultrasonographic Examination for the Diagnosis of Erosive Rheumatoid Arthritis Versus Erosive Osteoarthritis with Radiography Considered As Gold Standard

    Camille Roux1, Frédérique Gandjbakhch2, Audrey Pierreisnard3, Marion Couderc4, Cédric Lukas5, Racha Masri1, Jean-Philippe Sommier1, Isabelle Clerc-Urmès6, Cedric Baumann7, Isabelle Chary-Valckenaere8 and Damien Loeuille1, 1Rheumatology, CHRU Nancy, Vandoeuvre les Nancy, France, 2UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France, 3APHP, Paris, France, 4Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 5Rheumatology, CHU Lapeyronie and EA2415, Montpellier University, University of Montpellier, France, 6CHRU Nancy, Nancy, France, 7CHRU Nancy, Vandoeuvre les Nancy, France, 8Rheumatology, CHRU Nancy, Vandoeuvres les Nancy, France

    Background/Purpose: Rheumatoid arthritis (RA) is the most prevalent chronic inflammatory joint disease (1,2) responsible for structural damage. Radiography (RX) is considered as the gold standard…
  • Abstract Number: 1445 • 2018 ACR/ARHP Annual Meeting

    MRI Bone Erosions in RA Patients Relatives with Clinically Suspicious Arthralgia

    David Vega-Morales1, Jorge Esquivel-Valerio2, Mario Alberto Garza-Elizondo3, Dionicio A. Galarza-Delgado4, Miguel A Villarreal-Alarcón5, Cassandra Skinner-Taylor1, Diana Flores-Alvarado6, Janett Riega-Torres7, Lorena Pérez-Barbosa8, Brenda Vazquez-Fuentes9 and Maria Del Carmen Larios-Forte1, 1Rheumatology, University Hospital “Dr. José Eleuterio González”, UANL, Monterrey, Mexico, 2Rheumatology, University Hospital “Dr. José Eleuterio González”, UANL, Mexico, Monterrey, Mexico, 3Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, 4Chief of Rheumatology, Hospital Universitario, UANL, Monterrey, Mexico, 5Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. Jose Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 6Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico, 7University Hospital “Dr. José Eleuterio González”, UANL, Monterrey, Mexico, 8Hospital Universitario, Monterrey, Mexico, 9Servicio de Reumatología, Departamento de Medicina Interna. Hospital Universitario “Dr. José Eleuterio González”. Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Rheumatoid arthritis (RA) has a preclinical phase without symptoms that progress to symptomatic phases. Clinically suspect arthralgia (CSA) refers to patients with symptoms without…
  • « Previous Page
  • 1
  • …
  • 1098
  • 1099
  • 1100
  • 1101
  • 1102
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology